424 related articles for article (PubMed ID: 29667004)
1. The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.
Liu H; Su X; Si L; Lu L; Jiang S
Protein Cell; 2018 Jul; 9(7):596-615. PubMed ID: 29667004
[TBL] [Abstract][Full Text] [Related]
2. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
3. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing Antibodies Targeting HIV-1 gp41.
Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
6. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
[TBL] [Abstract][Full Text] [Related]
7. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
Melnychuk L; Ajamian L; Jean-Pierre P; Liang J; Gheorghe R; Wainberg MA; Zaharatos GJ
Vaccine; 2017 May; 35(20):2736-2744. PubMed ID: 28392143
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
9. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
Virology; 2017 May; 505():113-126. PubMed ID: 28237764
[TBL] [Abstract][Full Text] [Related]
11. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
PLoS One; 2011; 6(5):e14813. PubMed ID: 21625584
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.
Habte HH; Banerjee S; Shi H; Qin Y; Cho MW
Virology; 2015 Dec; 486():187-97. PubMed ID: 26454663
[TBL] [Abstract][Full Text] [Related]
13. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
Kim S; Filsinger Interrante MV; Kim PS
J Virol; 2023 Jan; 97(1):e0164722. PubMed ID: 36541800
[TBL] [Abstract][Full Text] [Related]
14. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.
Montero M; van Houten NE; Wang X; Scott JK
Microbiol Mol Biol Rev; 2008 Mar; 72(1):54-84, table of contents. PubMed ID: 18322034
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
[TBL] [Abstract][Full Text] [Related]
16. Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules.
Gach JS; Leaman DP; Zwick MB
Curr Top Med Chem; 2011 Dec; 11(24):2997-3021. PubMed ID: 22044228
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.
Bradley T; Trama A; Tumba N; Gray E; Lu X; Madani N; Jahanbakhsh F; Eaton A; Xia SM; Parks R; Lloyd KE; Sutherland LL; Scearce RM; Bowman CM; Barnett S; Abdool-Karim SS; Boyd SD; Melillo B; Smith AB; Sodroski J; Kepler TB; Alam SM; Gao F; Bonsignori M; Liao HX; Moody MA; Montefiori D; Santra S; Morris L; Haynes BF
EBioMedicine; 2016 Oct; 12():196-207. PubMed ID: 27612593
[TBL] [Abstract][Full Text] [Related]
18. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
Venditto VJ; Wieczorek L; Molnar S; Teque F; Landucci G; Watson DS; Forthal D; Polonis VR; Levy JA; Szoka FC
Clin Vaccine Immunol; 2014 Aug; 21(8):1086-93. PubMed ID: 24872518
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Pinto D; Fenwick C; Caillat C; Silacci C; Guseva S; Dehez F; Chipot C; Barbieri S; Minola A; Jarrossay D; Tomaras GD; Shen X; Riva A; Tarkowski M; Schwartz O; Bruel T; Dufloo J; Seaman MS; Montefiori DC; Lanzavecchia A; Corti D; Pantaleo G; Weissenhorn W
Cell Host Microbe; 2019 Nov; 26(5):623-637.e8. PubMed ID: 31653484
[TBL] [Abstract][Full Text] [Related]
20. Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.
Wang Q; Esnault F; Zhao M; Chiu TJ; Smith AB; Nguyen HT; Sodroski JG
J Virol; 2022 Apr; 96(7):e0187821. PubMed ID: 35289647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
